A study published in the Journal of the American Medical Association (JAMA) has found that some antipsychotics like Seroquel are less likely to cause serious side effects than older medications. The researchers, from the University of California, Los Angeles, and the California Department of Veterans Affairs, are conducting a new study to test the effects of Seroquel on the safety of older antipsychotics.
Researchers recruited 18,976 adults with dementia-related conditions between the ages of 12 and 65 to participate in a study using a validated, long-acting, flexible-dose, single-arm, randomized study design. The patients were assigned randomly to receive one of three antipsychotic treatments, either quetiapine (Seroquel) or a placebo, or to receive the other drug as a single treatment. The study patients were randomized to receive a standard dose of quetiapine (60 mg daily) or placebo in addition to other conventional treatment options for their symptoms of dementia.
The researchers analyzed the outcomes of those participants who received quetiapine or placebo. Quetiapine was not associated with an increased risk of heart failure, stroke, and death in the quetiapine group, compared to the placebo group. These findings were supported by other observational studies that found no association between quetiapine use and an increased risk of heart failure, stroke, or death. However, researchers found that quetiapine patients had a lower risk of being hospitalized and were less likely to die from any adverse event, compared to placebo patients.
Quetiapine is a type of antipsychotic medication that is used to treat symptoms associated with schizophrenia and bipolar disorder. Unlike traditional antipsychotics, quetiapine works by altering the balance of neurotransmitters in the brain, which may lead to a decrease in dopamine and serotonin levels in the brain, and to the reduction of serotonin in the brain. This mechanism makes it more effective for treating psychotic disorders. However, while it has been shown that patients treated with quetiapine are less likely to experience any side effects, this does not mean that they will not experience them, the researchers cautioned.
Seroquel is available as an extended-release formulation, and as an oral tablet. It is prescribed for schizophrenia and bipolar disorder in combination with other treatments for depression. In the study, researchers found that quetiapine patients treated with quetiapine were less likely to experience any side effects than those treated with placebo. Patients receiving quetiapine were also less likely to develop adverse events from quetiapine.
The researchers also cautioned that quetiapine is a long-acting, long-acting, flexible-dose, long-acting, long-lasting medication that should be taken as prescribed by a doctor. They added that quetiapine should be taken at least two hours before or after a meal to avoid any interference with the medication’s effectiveness. The researchers cautioned that the study patients were not randomly assigned to quetiapine or placebo, but were given the drug at bedtime.
The researchers also cautioned that the study patients were given a placebo or quetiapine, which is believed to work by altering the balance of neurotransmitters in the brain. However, they said that this was only an observation, and that the findings had limitations. The researchers noted that they were not testing the effects of quetiapine on schizophrenia or bipolar disorder.
In addition to the new findings, the researchers also noted that the study patients had other health benefits. They noted that the study patients had more stable cognitive function and did not experience any side effects. The researchers also noted that the study patients were more likely to report improved sleep quality, fewer sleep disturbances, lower blood pressure, and better mental status compared to the control group.
A study is currently being conducted to test whether the new study findings are consistent with other published studies. This is the first time that quetiapine has been shown to be associated with an increased risk of dementia-related conditions. The study’s results also suggest that the newer antipsychotic medications may be safer for people with dementia-related conditions.
COPYRIGHT: The Associated PressSource:
Citation:Anastasia M. Bresch, J. W. Lee, J. M. McVary, S. D. Williams, S. H. Smith, D. L. Smith, J. Williams, J. Jones, J. A. Smith, and E. E. Smith (2015, June 8).AstraZeneca today announced that the European Medicines Agency (EMA) has approved its approval for its SEROQUEL XR product (quetiapine fumarate). SEROQUEL XR, is a once-daily formulation of SEROQUEL marketed as Seroquel XR. The approved indication for SEROQUEL XR is in the treatment of schizophrenia and mixed episodes. SEROQUEL XR is indicated for the treatment of both acute and maintenance psychotic symptoms in adults and children aged 16 years and over.
“In summary, the FDA has determined that SEROQUEL XR is an effective, safe, well-tolerated and well tolerated SEROQUEL in the treatment of patients with schizophrenia and mixed episodes. We are pleased to see the FDA’s submission that SEROQUEL XR is now available to be administered in over-the-counter form.”
“We are delighted to be approving this important new indication for SEROQUEL XR,” said EMA Director of Research Dr. David Brown. “We are also very pleased to have this product in the U. S. and globally.”
“In addition to the approved indications, this product is a novel treatment option for acute and maintenance psychotic symptoms in adults and children with schizophrenia and mixed episodes,” said EMA Chief Executive Officer Frank Schmitz. “Seroquel XR is now a leading indication for patients and clinicians globally. We look forward to the FDA’s submission that SEROQUEL XR is now available to be administered in over-the-counter form.”
In accordance with the U. Food and Drug Administration (FDA) website, SEROQUEL XR is the generic equivalent of AstraZeneca’s Seroquel (quetiapine fumarate) in the following categories:
“Seroquel XR is an important tool in the development of new drugs for schizophrenia and mixed episodes, and we look forward to its continued relevance in the management of these conditions,” said David Brown, Chief Executive Officer. “We are pleased to have the FDA’s submission that SEROQUEL XR is now available to be administered in over-the-counter form.”
The European Medicines Agency (EMA) has approved the approval of SEROQUEL XR for the treatment of schizophrenia and mixed episodes.
“In addition to the approved indications, the drug is indicated for the treatment of acute and maintenance psychotic symptoms in adults and children aged 16 years and over,” stated Dr. Brown. “Seroquel XR is the first of a new class of medications to be approved to treat both schizophrenia and mixed episodes. It is a unique formulation of SEROQUEL that is designed to provide quick and reliable treatment for patients with schizophrenia and mixed episodes.”
“In summary, the FDA has determined that SEROQUEL XR is an effective, well-tolerated and well-tolerated SEROQUEL in the treatment of patients with schizophrenia and mixed episodes,” said EMA Chief Executive Officer David Brown. “We are pleased to be approving this important new indication for SEROQUEL XR.
Seroquel (Quetiapine) can be purchased by calling +1-888-704-0408 and talking with a customer service representative, or by placing an online order at liferxpharmacy.com. Customer Support is also aided by using the chat feature. For additional information, visit the "How to Order" page on liferxpharmacy.com.
Seroquel (Quetiapine) is a medication that can only be purchased with a doctors prescription. While processing your order for the medication, it is necessary to get a valid prescription from your doctor The prescription can be scanned, emailed, or uploaded at liferxpharmacy.com or fax on +1-800-986-4751 Alternatively, if you like, we can even contact your doctor to obtain a valid prescription.
The maximum amount of Seroquel (Quetiapine) can be ordered at one time is a 90-day supply. The amount that can be ordered is dependent on the instructions and quantity mentioned on your medical prescription. Refilling alternate is always available for future needs.
It is a completely safe and secure choice to order your medicine from us. We function similarly alike any other traditional pharmacy, intending to serve safe and affordable prescription medicines. Our associated pharmacists are functional in many countries and are completely licensed and certified.
Seroquel (Quetiapine) is available in both generic and brand form. Generic medicines contain the same active components as brand-name pharmaceuticals have. They ensure and meet the same quality, strength, and purity standards in comparison to any other brand.
Yes. We deliver all around the United States and other major countries.
LifeRx pharmacy makes it simple to refill your medication. By going to your accounts reorder section, you can easily place a refill option available online. You may examine your prior orders and choose which prescriptions order needs to be refilled. To order a refill, you can also call us and chat with one of our customer service representatives. Our live chat is also one of the convenient ways to reach out to us while placing a refill order.
We do not automatically refill prescriptions as it might be the case where you may no longer be taking the same medicines or your doctor may have revised your dose, among other things. However, we do offer a helpful refill reminder service. Based on your prescription history, we may call or email you to let you know when the ideal time is to place a refill order.
Appardirol refill refillLifesci tobill, cin.ast.com (tobuy), (tobubber), (tobuy), (tobuy), (tobuy), (tobuy), (tobubber) and tobat (tobart) all increase total creatinine levels.
Seroquel® (quetiapine) is a widely used antianxiety medication primarily used to treat anxiety disorders.
The market for quetiapine is experiencing significant growth, driven by several factors.
Market Growth Drivers
The rise of generic drugs and the rise of e-commerce platforms are major drivers for market growth.
Regional Market Insights
The global seroquel market is poised for significant growth, driven by several key regions:
Financial Impact
Financial pressures and the COVID-19 pandemic have led to a decline in market share for seroquel. The market will also suffer from the impact of the oncology drugs market, as well as the impact of pharmaceutical sales.
Technological and Manufacturing Factors
Technological and manufacturing factors have been key drivers in the seroquel market. The growing demand for quetiapine for anxiety disorders is expected to enhance market growth.
Price Trends and Factors
The cost of quetiapine can vary significantly based on several factors:
Price Drops and Restraints
Price Trends and Forecast
Market Dynamics
The global seroquel market is influenced by several factors, including:
Technological and manufacturing factors are expected to increase the market share of seroquel, driving the prices of quetiapine higher.
Show ratings & reviews for
This medication has worked for me.
This medication has been easy for me to use.
Overall, I have been satisfied with my experience.
37People found this comment helpful
I started on Seroquel at age 4. At age 12, it was like having a baby...not very young. I was in my 40s and was having difficulty sleeping. I used to sleep with my legs all out. I was on a low dose of Seroquel for about 4 months. I felt that I was getting tired and needed to get off the medication. I was concerned that I was not really taking care of myself. I was concerned that I was taking too much of the drug. I thought I was taking too much. I thought I was having a bad reaction. I started on a low dose of Seroquel, then I stopped. I was concerned that I was not taking care of myself. I was concerned that I was taking too much. I started off on a low dose of Seroquel but then I stopped.
Stade de France Pharmacy